chartexchange

CLNN
Clene Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:50 PM EST
3.43USD+6.522%(+0.21)239,332
After-hoursNov 18, 2026 4:00:30 PM EST
3.42USD-0.292%(-0.01)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Salt Lake City, UT, USA
Previous Close
$3.22
Beta
1.68
52-Week High
$10.84 2025-12-01
52-Week Low
$3.02 2026-10-16
SMA 50
$3.88
SMA 200
$5.13
Avg. Vol 10D
131,608
Avg. Vol 30D
96,533
Avg. Vol 90D
100,807
Relative Vol
2.48
11.46M
1.7800%
1,476
Jul 11, 2024 · 1-for-20 (reverse)
CLNN Profile

clene has a new vision for a pharmaceutical future using therapeutic elements in clean, new nanoforms. our patented clean-surface nanosuspension™ (csn) technology produces clean-surface nanocrystals at commercially viable rates. by coupling high-purity metallic donor materials with high-purity water, csn unlocks the potential of therapeutic nanoparticles and represents a clean break from the standard paradigm of small-molecule drugs and large-molecule biologics.

CLNN Performance
PeriodPriceDateChangeBeta
1W4.202026-11-11-19.67%2.591
1M3.292026-10-19+2.43%2.134
3M4.092026-08-18-17.60%1.897
6M6.792026-05-18-50.37%1.701
1Y8.562025-11-18-60.63%1.677
2Y4.402024-11-18-23.41%—
5Y105.602021-11-18-96.81%0.898
CLNN Stock Summary

Clene Inc. Common Stock (NASDAQ:CLNN) stock price today is $3.37, and today's volume is 239,666. CLNN is up 4.658% today. The 30 day average volume is 96,533. CLNN market cap is $48.53M with 14.40M shares outstanding.